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To the Editor:
We read with great interest the report of the first case
of eosinophilic esophagitis (EE) in Asia, incidentally
found during upper endoscopy screening for gastric
cancer in an asymptomatic Chinese adult, which ful-
filled endoscopic and histopathologic criteria for EE.1
Indeed, the Kalixanda study,2 the first assessment on the
prevalence of EE in an adult asymptomatic population,
has sketched a potential scenario in which EE in symp-
tomatic adults may only represent the tip of the iceberg,
in the same way as celiac disease, whilst asymptomatic
or oligosymptomatic patients are commonly missed.
Notwithstanding, several remarks on this issue
should be discussed. In the Kalixanda study, possible
EE was defined if 5–14eo/HPF, probable EE if ≥15 to
< 20 eo/HPF, and definite EE if ≥ 20 eo/HPF. Despite
the patients enrolled not having consulted a doctor 
in the previous year, the rate of patients with erosive
esophagitis or troublesome reflux symptoms (possible
EE [13/25, 10/25], probable EE [2/7, 3/7], definite
EE [0/4, 3/4], respectively) was significantly high,
indicating that it was not a fully asymptomatic popu-
lation sample and that severe gastroesophageal reflux
disease (GERD) may occur with minor or absent clin-
ical impact. As such, the recent American Gastroen-
terology Association review on the management of
GERD3 has focused on the artificial division in the
Montreal consensus between GERD and episodic
heartburn, since reflux may not be perceived by the
patient to be troublesome due to insufficient frequency
or severity, but may be equally responsive to proton
pump inhibitors (PPI) in clinical and histopathologic
terms. Of note, the authors point out that the inci-
dence of GERD is increasingly growing in Asia due to
obesity and diet, as has occurred during the last decade
in the West. In this regard, our group recently reported
2 young males suffering from recurrent food impaction
with histopathologic features of EE.4 Neither of the
patients had classical symptoms of GERD (heartburn,
regurgitation, nausea, epigastric or chest pain) but both
had endoscopic reflux features and 1 had clinicopatho-
logic remission on PPI therapy.
The recent first consensus statement on the diag-
nosis of EE5 has established the need of precluding
GERD by means of pH testing or high-dose PPI as a
major premise before diagnosing EE. Unfortunately,
no histopathologic follow-up after acid suppression
was done in the Kalixanda study or in the Chinese
patient. EE has been historically diagnosed based on
histopathologic criteria due to the common belief that
GERD is related to a low-grade intraepithelial eosino-
philic infiltration, commonly < 7 eo/HPF. In contrast
to this belief, recent reports have demonstrated that
GERD may induce esophageal high-grade eosinophil
recruitment similar to that found in EE.6
In conclusion, a PPI trial is mandatory before
diagnosing EE in patients fulfilling histopathologic
criteria for EE, regardless of clinical and endoscopic
features. We strongly encourage the authors of the
Asian report to assess the histopathologic outcome of
this patient after acid suppression in order to preclude
GERD definitely.
Javier Molina-Infante*, 
Moises Hernandez-Alonso,
Belen Perez-Gallardo, 
Elisa Martin-Noguerol
Unit of Gastroenterology,
Hospital San Pedro de Alcántara,
Avda. Pablo Naranjo s/n,
10003 Cáceres, 
Spain.
*Corresponding author: xavi_molina@hotmail.com
References
1. Lu HC, Lu CL, Chang FY. Eosinophilic esophagitis in an
asymptomatic Chinese. J Chin Med Assoc 2008;71:362–4. 
2. Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson 
SE, Lind T, Bolling-Sternevald E, et al. Prevalence of oesoph-
ageal eosinophils and eosinophilic oesophagitis in adults: the 
population-based Kalixanda study. Gut 2007;56:615–20.
3. Kahrilas PJ, Shaheen NJ, Vaezi M. American Gastroenterologi-
cal Association Institute technical review on the management
of gastroesophageal reflux disease. Gastroenterology 2008;135;
1383–91.
LETTERS TO THE EDITOR
The First Asian Case Report of Eosinophilic
Esophagitis in an Asymptomatic Adult: 
What About a Proton Pump Inhibitor Trial?
J Chin Med Assoc • March 2009 • Vol 72 • No 3 167
4. Molina-Infante J, Ferrando-Lamana L, Mateos-Rodríguez JM,
Pérez-Gallardo B, Prieto-Bermejo AB. Overlap of reflux and
eosinophilic esophagitis in two patients requiring different
therapies: a review of the literature. World J Gastroenterol
2008;14:1463–6.
5. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C,
Putnam PE, Bonis P, et al; First International Gastrointestinal
Eosinophil Research Symposium (FIGERS) Subcommittees.
Eosinophilic esophagitis in children and adults: a systematic
review and consensus recommendations for diagnosis and
treatment. Gastroenterology 2007;133:1342–63.
6. Rodrigo S, Abboud G, Oh D, DeMeester SR, Hagen J,
Lipham J, DeMeester TR, et al. High intraepithelial eosinophil
counts in esophageal squamous epithelium are not specific for
eosinophilic esophagitis in adults. Am J Gastroenterol 2008;
103:435–42.
